|4Dec 7, 6:56 PM ET

Glennon Michael J 4

4 · PAVmed Inc. · Filed Dec 7, 2022

Insider Transaction Report

Form 4
Period: 2022-12-05
Transactions
  • Purchase

    Common Stock

    2022-12-06$0.64/sh+88,000$56,082150,000 total
  • Purchase

    Common Stock

    2022-12-07$0.62/sh+100,000$62,320250,000 total
  • Purchase

    Common stock

    2022-12-05$0.69/sh+62,000$42,60662,000 total
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.67 to $0.6984 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.5930 to $0.6746 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.6122 to $0.6382 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES